ALAMEDA, Calif.--(BUSINESS WIRE)--AllCells (the “company”) announced today that its metropolitan Boston area tissue collection facility located at 500 Congress Street, Ste 1-A, Quincy, MA now offers healthy donor whole blood, whole bone marrow, and non-mobilized and mobilized donor (Filgrastim and/or Plerixafor) apheresis products with same-day fresh product delivery to researchers located in the Boston/Cambridge area, and next-day delivery across the US East Coast.
The new Quincy, MA facility expands AllCells’ LeukoLab operations with a second active donor pool that substantially increases the company’s total production capacity for human hematopoietic and immune cells. “Minimizing the time of fresh tissue collection from donor-to-customer is essential for ensuring consistently high cell viability - a top quality attribute for optimal product performance in numerous life science research applications. We’re now able to provide life science researchers located in Boston area/east coast region with the same high level of fresh tissue delivery service enjoyed by customers located in the San Francisco/west coast area,” said Lewis Chapman - VP, Global Commercial Operations.
For allogeneic cell therapy manufacturing applications, CliniCells™ Whole Bone Marrow and Leuko Pak products which contain clinically relevant cell types, are produced at the company’s US-FDA registered facilities in Alameda, CA. AllCells also provides cryopreserved primary cell products for research applications, such as CD34+ stem/progenitor cells, PBMCs, T-cells, monocytes, B-cells, neutrophils, basophils, eosinophils, NK cells, and many other cell types derived from healthy and diseased hematologic tissue using a positive or negative selection process.
For more information about the availability of research-grade or CliniCells™ clinical-grade products, contact us at 1-888-535-3444, or 1-510-521-2600, and email@example.com.
About AllCells, LLC
AllCells is a biotechnology company dedicated to providing researchers and biomanufacturing organizations with high quality primary cells that enable drug discovery, preclinical development, and manufacturing of cell therapies. Leveraging its expertise in hematopoietic and immune cell isolation and characterization together with on-site hematologic tissue clinical collection operations, AllCells maintains a large repository of donor profiles that can be qualified for various biomedical applications. Freshly collected tissue is immediately processed in contiguous manufacturing facilities to produce purified cell types having unparalleled quality and consistency. Cells are shipped worldwide, or fresh cells can be immediately utilized in fee-for-service cell-based assays (AllCellutions™) custom designed according to customer criteria. For more information, please visit www.allcells.com.